(KBR) KBR - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US48242W1062
Stock: Engineering, Technology, Government, Energy, Science
Total Rating 31
Risk 73
Buy Signal -0.66
| Risk 5d forecast | |
|---|---|
| Volatility | 30.6% |
| Relative Tail Risk | -13.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.62 |
| Alpha | -30.54 |
| Character TTM | |
|---|---|
| Beta | 0.577 |
| Beta Downside | 0.864 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.08% |
| CAGR/Max DD | -0.18 |
EPS (Earnings per Share)
Revenue
Description: KBR KBR March 04, 2026
KBR, Inc. is a global provider of scientific, technology, and engineering solutions to government and commercial clients. The company operates in two primary segments: Government Solutions and Sustainable Technology Solutions.
The Government Solutions segment offers a wide range of services, including research and development, systems engineering, cyber analytics, and program management, primarily for defense, intelligence, and space programs. This sector is characterized by long-term contracts and a focus on national security and technological advancement.
The Sustainable Technology Solutions segment provides proprietary process technologies for industries such as ammonia/syngas and petrochemicals. This segment also focuses on energy transition, decarbonization, and environmental impact solutions, reflecting a growing industry trend towards sustainable practices and reduced carbon footprints. Further research on ValueRay can provide detailed financial insights into these initiatives.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 415.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 1.38 > 1.0 |
| NWC/Revenue: 4.64% < 20% (prev 1.18%; Δ 3.46% < -1%) |
| CFO/TA 0.08 > 3% & CFO 524.0m > Net Income 415.0m |
| Net Debt (2.62b) to EBITDA (888.0m): 2.95 < 3 |
| Current Ratio: 1.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (129.0m) vs 12m ago -3.01% < -2% |
| Gross Margin: 14.67% > 18% (prev 0.14%; Δ 1453 % > 0.5%) |
| Asset Turnover: 118.1% > 50% (prev 116.1%; Δ 2.04% > 0%) |
| Interest Coverage Ratio: 4.33 > 6 (EBITDA TTM 888.0m / Interest Expense TTM 166.0m) |
Altman Z'' 2.04
| A: 0.06 (Total Current Assets 2.05b - Total Current Liabilities 1.69b) / Total Assets 6.58b |
| B: 0.26 (Retained Earnings 1.70b / Total Assets 6.58b) |
| C: 0.11 (EBIT TTM 719.0m / Avg Total Assets 6.62b) |
| D: 0.10 (Book Value of Equity 521.0m / Total Liabilities 5.07b) |
| Altman-Z'' Score: 2.04 = BBB |
Beneish M -3.27
| DSRI: 0.78 (Receivables 1.09b/1.38b, Revenue 7.82b/7.73b) |
| GMI: 0.97 (GM 14.67% / 14.25%) |
| AQI: 0.96 (AQ_t 0.62 / AQ_t-1 0.65) |
| SGI: 1.01 (Revenue 7.82b / 7.73b) |
| TATA: -0.02 (NI 415.0m - CFO 524.0m) / TA 6.58b) |
| Beneish M-Score: -3.27 (Cap -4..+1) = AA |
What is the price of KBR shares?
As of March 07, 2026, the stock is trading at USD 40.00 with a total of 2,290,626 shares traded.
Over the past week, the price has changed by -5.28%, over one month by -8.02%, over three months by -7.93% and over the past year by -18.98%.
Over the past week, the price has changed by -5.28%, over one month by -8.02%, over three months by -7.93% and over the past year by -18.98%.
Is KBR a buy, sell or hold?
KBR has received a consensus analysts rating of 4.67.
Therefore, it is recommended to buy KBR.
- StrongBuy: 7
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the KBR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 53.7 | 34.2% |
| Analysts Target Price | 53.7 | 34.2% |
KBR Fundamental Data Overview March 04, 2026
P/E Trailing = 12.8464
P/E Forward = 10.3627
P/S = 0.6781
P/B = 3.6041
P/EG = 0.5789
Revenue TTM = 7.82b USD
EBIT TTM = 719.0m USD
EBITDA TTM = 888.0m USD
Long Term Debt = 2.56b USD (from longTermDebt, two quarters ago)
Short Term Debt = 105.0m USD (from shortTermDebt, last quarter)
Debt = 3.12b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.62b USD (from netDebt column, last quarter)
Enterprise Value = 7.90b USD (5.28b + Debt 3.12b - CCE 500.0m)
Interest Coverage Ratio = 4.33 (Ebit TTM 719.0m / Interest Expense TTM 166.0m)
EV/FCF = 16.40x (Enterprise Value 7.90b / FCF TTM 482.0m)
FCF Yield = 6.10% (FCF TTM 482.0m / Enterprise Value 7.90b)
FCF Margin = 6.16% (FCF TTM 482.0m / Revenue TTM 7.82b)
Net Margin = 5.30% (Net Income TTM 415.0m / Revenue TTM 7.82b)
Gross Margin = 14.67% ((Revenue TTM 7.82b - Cost of Revenue TTM 6.67b) / Revenue TTM)
Gross Margin QoQ = 15.38% (prev 13.98%)
Tobins Q-Ratio = 1.20 (Enterprise Value 7.90b / Total Assets 6.58b)
Interest Expense / Debt = 1.44% (Interest Expense 45.0m / Debt 3.12b)
Taxrate = 26.14% (40.0m / 153.0m)
NOPAT = 531.0m (EBIT 719.0m * (1 - 26.14%))
Current Ratio = 1.22 (Total Current Assets 2.05b / Total Current Liabilities 1.69b)
Debt / Equity = 2.08 (Debt 3.12b / totalStockholderEquity, last quarter 1.50b)
Debt / EBITDA = 2.95 (Net Debt 2.62b / EBITDA 888.0m)
Debt / FCF = 5.44 (Net Debt 2.62b / FCF TTM 482.0m)
Total Stockholder Equity = 1.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.27% (Net Income 415.0m / Total Assets 6.58b)
RoE = 28.27% (Net Income TTM 415.0m / Total Stockholder Equity 1.47b)
RoCE = 17.86% (EBIT 719.0m / Capital Employed (Equity 1.47b + L.T.Debt 2.56b))
RoIC = 12.92% (NOPAT 531.0m / Invested Capital 4.11b)
WACC = 5.45% (E(5.28b)/V(8.40b) * Re(8.04%) + D(3.12b)/V(8.40b) * Rd(1.44%) * (1-Tc(0.26)))
Discount Rate = 8.04% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.27%
[DCF] Terminal Value 88.03% ; FCFF base≈447.6m ; Y1≈528.2m ; Y5≈812.1m
[DCF] Fair Price = 166.4 (EV 23.76b - Net Debt 2.62b = Equity 21.13b / Shares 127.0m; r=5.90% [WACC]; 5y FCF grow 19.19% → 2.90% )
EPS Correlation: 92.19 | EPS CAGR: 13.29% | SUE: 1.04 | # QB: 2
Revenue Correlation: 84.57 | Revenue CAGR: 2.57% | SUE: -0.91 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.93 | Chg7d=-0.054 | Chg30d=-0.054 | Revisions Net=-4 | Analysts=7
EPS current Year (2026-12-31): EPS=4.02 | Chg7d=-0.021 | Chg30d=-0.021 | Revisions Net=+0 | Growth EPS=+2.3% | Growth Revenue=+3.7%
EPS next Year (2027-12-31): EPS=4.31 | Chg7d=-0.002 | Chg30d=-0.002 | Revisions Net=+2 | Growth EPS=+7.1% | Growth Revenue=+5.6%
[Analyst] Revisions Ratio: -1.00 (0 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.3% (Discount Rate 8.0% - Earnings Yield 7.8%)
[Growth] Growth Spread = -2.6% (Analyst -2.4% - Implied 0.3%)
P/E Forward = 10.3627
P/S = 0.6781
P/B = 3.6041
P/EG = 0.5789
Revenue TTM = 7.82b USD
EBIT TTM = 719.0m USD
EBITDA TTM = 888.0m USD
Long Term Debt = 2.56b USD (from longTermDebt, two quarters ago)
Short Term Debt = 105.0m USD (from shortTermDebt, last quarter)
Debt = 3.12b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.62b USD (from netDebt column, last quarter)
Enterprise Value = 7.90b USD (5.28b + Debt 3.12b - CCE 500.0m)
Interest Coverage Ratio = 4.33 (Ebit TTM 719.0m / Interest Expense TTM 166.0m)
EV/FCF = 16.40x (Enterprise Value 7.90b / FCF TTM 482.0m)
FCF Yield = 6.10% (FCF TTM 482.0m / Enterprise Value 7.90b)
FCF Margin = 6.16% (FCF TTM 482.0m / Revenue TTM 7.82b)
Net Margin = 5.30% (Net Income TTM 415.0m / Revenue TTM 7.82b)
Gross Margin = 14.67% ((Revenue TTM 7.82b - Cost of Revenue TTM 6.67b) / Revenue TTM)
Gross Margin QoQ = 15.38% (prev 13.98%)
Tobins Q-Ratio = 1.20 (Enterprise Value 7.90b / Total Assets 6.58b)
Interest Expense / Debt = 1.44% (Interest Expense 45.0m / Debt 3.12b)
Taxrate = 26.14% (40.0m / 153.0m)
NOPAT = 531.0m (EBIT 719.0m * (1 - 26.14%))
Current Ratio = 1.22 (Total Current Assets 2.05b / Total Current Liabilities 1.69b)
Debt / Equity = 2.08 (Debt 3.12b / totalStockholderEquity, last quarter 1.50b)
Debt / EBITDA = 2.95 (Net Debt 2.62b / EBITDA 888.0m)
Debt / FCF = 5.44 (Net Debt 2.62b / FCF TTM 482.0m)
Total Stockholder Equity = 1.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.27% (Net Income 415.0m / Total Assets 6.58b)
RoE = 28.27% (Net Income TTM 415.0m / Total Stockholder Equity 1.47b)
RoCE = 17.86% (EBIT 719.0m / Capital Employed (Equity 1.47b + L.T.Debt 2.56b))
RoIC = 12.92% (NOPAT 531.0m / Invested Capital 4.11b)
WACC = 5.45% (E(5.28b)/V(8.40b) * Re(8.04%) + D(3.12b)/V(8.40b) * Rd(1.44%) * (1-Tc(0.26)))
Discount Rate = 8.04% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.27%
[DCF] Terminal Value 88.03% ; FCFF base≈447.6m ; Y1≈528.2m ; Y5≈812.1m
[DCF] Fair Price = 166.4 (EV 23.76b - Net Debt 2.62b = Equity 21.13b / Shares 127.0m; r=5.90% [WACC]; 5y FCF grow 19.19% → 2.90% )
EPS Correlation: 92.19 | EPS CAGR: 13.29% | SUE: 1.04 | # QB: 2
Revenue Correlation: 84.57 | Revenue CAGR: 2.57% | SUE: -0.91 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.93 | Chg7d=-0.054 | Chg30d=-0.054 | Revisions Net=-4 | Analysts=7
EPS current Year (2026-12-31): EPS=4.02 | Chg7d=-0.021 | Chg30d=-0.021 | Revisions Net=+0 | Growth EPS=+2.3% | Growth Revenue=+3.7%
EPS next Year (2027-12-31): EPS=4.31 | Chg7d=-0.002 | Chg30d=-0.002 | Revisions Net=+2 | Growth EPS=+7.1% | Growth Revenue=+5.6%
[Analyst] Revisions Ratio: -1.00 (0 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.3% (Discount Rate 8.0% - Earnings Yield 7.8%)
[Growth] Growth Spread = -2.6% (Analyst -2.4% - Implied 0.3%)